These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11738736)
1. Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. da Cruz FW; McBride AJ; Conceição FR; Dale JW; McFadden J; Dellagostin OA Vaccine; 2001 Dec; 20(5-6):731-6. PubMed ID: 11738736 [TBL] [Abstract][Full Text] [Related]
2. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines. Perrin P; Jacob Y; Desmézières E; Tordo N Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236 [TBL] [Abstract][Full Text] [Related]
4. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Xiang ZQ; Yang Y; Wilson JM; Ertl HC Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532 [TBL] [Abstract][Full Text] [Related]
5. Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG. Thole JE; van Schooten WC; Keulen WJ; Hermans PW; Janson AA; de Vries RR; Kolk AH; van Embden JD Infect Immun; 1988 Jun; 56(6):1633-40. PubMed ID: 2453469 [TBL] [Abstract][Full Text] [Related]
6. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
7. Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine? Drings A; Jallet C; Chambert B; Tordo N; Perrin P Vaccine; 1999 Mar; 17(11-12):1549-57. PubMed ID: 10195792 [TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals. Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098 [TBL] [Abstract][Full Text] [Related]
11. Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Sumner JW; Fekadu M; Shaddock JH; Esposito JJ; Bellini WJ Virology; 1991 Aug; 183(2):703-10. PubMed ID: 1840709 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Aldovini A; Young RA Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750 [TBL] [Abstract][Full Text] [Related]
13. Stable expression and secretion of the B-cell epitope of rodent malaria from Mycobacterium bovis BCG and induction of long-lasting humoral response in mouse. Matsumoto S; Yanagi T; Ohara N; Wada N; Kanbara H; Yamada T Vaccine; 1996 Jan; 14(1):54-60. PubMed ID: 8821650 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Dennehy M; Bourn W; Steele D; Williamson AL Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069 [TBL] [Abstract][Full Text] [Related]
15. New use of BCG for recombinant vaccines. Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554 [TBL] [Abstract][Full Text] [Related]
16. Rabies vaccine development by expression of recombinant viral glycoprotein. Astray RM; Jorge SA; Pereira CA Arch Virol; 2017 Feb; 162(2):323-332. PubMed ID: 27796547 [TBL] [Abstract][Full Text] [Related]
17. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep. Bouet-Cararo C; Contreras V; Fournier A; Jallet C; Guibert JM; Dubois E; Thiery R; Bréard E; Tordo N; Richardson J; Schwartz-Cornil I; Zientara S; Klonjkowski B Vaccine; 2011 Feb; 29(6):1304-10. PubMed ID: 21134446 [TBL] [Abstract][Full Text] [Related]
18. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation. Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458 [No Abstract] [Full Text] [Related]
19. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
20. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector. Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]